1. Home
  2. KMDA vs MCS Comparison

KMDA vs MCS Comparison

Compare KMDA & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kamada Ltd.

KMDA

Kamada Ltd.

HOLD

Current Price

$8.22

Market Cap

501.8M

Sector

Health Care

ML Signal

HOLD

Logo Marcus Corporation (The)

MCS

Marcus Corporation (The)

HOLD

Current Price

$18.33

Market Cap

479.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMDA
MCS
Founded
1990
1935
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
501.8M
479.7M
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
KMDA
MCS
Price
$8.22
$18.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$14.00
$23.75
AVG Volume (30 Days)
76.2K
106.2K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
3.02%
1.74%
EPS Growth
N/A
N/A
EPS
N/A
0.77
Revenue
N/A
$758,458,000.00
Revenue This Year
$13.94
$12.05
Revenue Next Year
$9.84
$3.15
P/E Ratio
$24.59
$23.95
Revenue Growth
N/A
3.11
52 Week Low
$5.54
$12.85
52 Week High
$9.35
$18.80

Technical Indicators

Market Signals
Indicator
KMDA
MCS
Relative Strength Index (RSI) 43.22 70.73
Support Level $7.96 $14.66
Resistance Level $8.30 N/A
Average True Range (ATR) 0.20 0.51
MACD -0.02 0.20
Stochastic Oscillator 29.21 92.98

Price Performance

Historical Comparison
KMDA
MCS

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

Share on Social Networks: